Celgene Bid To Ax FCA Suit Is Premature, US Says
The U.S. government on Thursday weighed in on Celgene Corp.'s bid to nix a whistleblower's False Claims Act suit in California federal court over alleged off-label drug promotions and kickbacks to...To view the full article, register now.
Already a subscriber? Click here to view full article